Sarepta Therapeutics, Inc.
SRPT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000873303
No open-market purchases or sales by Sarepta Therapeutics, Inc. insiders were filed in the last 90 days; 323 institutions reported holding it in 13F filings for Q2 2026, worth $1.94B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Sarepta Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Sarepta Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wong Ryan Ho-Yan | Chief Financial Officer | 121,792 | Sep 8, 2026 | 5 |
| Estepan Ian Michael | Chief Operating Officer | 177,184 | Sep 8, 2026 | 7 |
| Rothfuss Cristin | EVP, General Counsel | 115,519 | Sep 8, 2026 | 5 |
| Rodino-Klapac Louise | President, R&D and Tech Ops | 203,900 | Sep 8, 2026 | 6 |
| Severino Michael | Chief Executive Officer | 756,104 | Jul 29, 2026 | 1 |
| Behrens M Kathleen | Director | 214,357 | Jun 5, 2026 | 2 |
| Connelly Deirdre P | Director | 22,100 | Jun 5, 2026 | 1 |
| Wigzell Hans Lennart Rudolf | Director | 42,098 | Jun 5, 2026 | 1 |
| Barry Richard | Director | 2,983,542 | Jun 5, 2026 | 1 |
| Nicaise Claude | Director | 48,407 | Jun 5, 2026 | 2 |
| Boor Kathryn Jean | Director | 25,138 | Jun 5, 2026 | 1 |
| Mayo Stephen | Director | 18,640 | Jun 5, 2026 | 2 |
| Chambers Michael Andrew | Director | 27,535 | Jun 5, 2026 | 2 |
| Ingram Douglas S | Chief Executive Officer | 929,391 | Dec 9, 2025 | 1 |
| Arif Bilal | Chief Tech Ops Officer | 32,500 | Aug 6, 2025 | 0 |
| Murray Dallan | Chief Customer Officer | 38,202 | Mar 11, 2025 | 0 |
| Brown Ryan Edward | EVP, General Counsel | 17,129 | Jun 25, 2024 | 0 |
| Gray Mary Ann | Director | 12,356 | Mar 8, 2022 | 0 |
| Ciambrone William | EVP | 22,099 | Mar 8, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 (view filing) | Mar 12 | 1 day | Mayo StephenDirector | SSale | −7.24K | $17.02 | −$123.2K | −80.4%1.76K after | |
| Dec 18, 2025 (view filing) | Dec 16 | 2 days | Estepan Ian MichaelChief Operating Officer | SSale | −13.2K | $22.31 | −$294.2K | −6.4%193.3K after | |
| Mar 13, 2025 (view filing) | Mar 12 | 1 day | Nicaise ClaudeDirector | SSale | −2.49K | $99.64 | −$248.2K | −8.2%27.8K after | |
| Dec 16, 2024 (view filing) | Dec 12 | 4 days | Wigzell Hans Lennart RudolfDirector | SSale | −10.5K | $124.84 | −$1.31M | −31.5%22.8K after | |
| Dec 6, 2024 (view filing) | Dec 5 | 1 day | Boor Kathryn JeanDirector | SSale | −1.64K | $125.55 | −$205.4K | −21.8%5.88K after | |
| Sep 3, 2024 (view filing) | Aug 30 | 4 days | Estepan Ian MichaelChief Financial Officer | SSale | −5.99K | $137.36 | −$822.1K | −15.0%33.9K after | |
| Aug 20, 2024 (view filing) | Aug 16 | 4 days | Chambers Michael AndrewDirector | PPurchase | +37.0K | $133.80 | +$4.96M | +15.0%284.0K after | 3 lots |
| Jun 25, 2024 (view filing) | Jun 25 | Same day | Brown Ryan EdwardEVP, General Counsel | SSale | −39.0K | $161.61 | −$6.30M | −69.5%17.1K after | 7 lots10b5-1 |
| Jun 25, 2024 (view filing) | Jun 24-25 | 1 day | Arif BilalChief Tech Ops Officer | SSale | −11.8K | $163.13 | −$1.92M | −40.4%17.4K after | 6 lots10b5-1 |
| May 6, 2024 (view filing) | May 2 | 4 days | Murray DallanChief Customer Officer | SSale | −3.63K | $140.00 | −$508.9K | −16.7%18.1K after | 10b5-1 |
| Mar 11, 2024 (view filing) | Mar 8 | 3 days | Wigzell Hans Lennart RudolfDirector | SSale | −15.0K | $123.25 | −$1.85M | −39.6%22.8K after | 3 lots |
| Mar 11, 2024 (view filing) | Mar 11 | Same day | Boor Kathryn JeanDirector | SSale | −761 | $122.93 | −$93.5K | −9.2%7.52K after | |
| Mar 6, 2024 (view filing) | Mar 5 | 1 day | Mayo StephenDirector | SSale | −3.13K | $122.96 | −$385.5K | −32.1%6.62K after | |
| Mar 5, 2024 (view filing) | Mar 1 | 4 days | Brown Ryan EdwardEVP, General Counsel | SSale | −2.00K | $125.34 | −$250.7K | −5.9%31.8K after | |
| Mar 5, 2024 (view filing) | Mar 1 | 4 days | Arif BilalChief Tech Ops Officer | SSale | −2.00K | $128.84 | −$257.7K | −6.9%26.8K after | 2 lots |
| Mar 5, 2024 (view filing) | Mar 1 | 4 days | Estepan Ian MichaelChief Financial Officer | SSale | −1.20K | $128.30 | −$154.0K | −3.0%39.1K after | |
| Nov 6, 2023 (view filing) | Nov 3 | 3 days | Barry RichardDirector | PPurchase | +50.0K | $78.81 | +$3.94M | +55.6%140.0K after | 2 lots |
| Nov 6, 2023 (view filing) | Nov 3 | 3 days | Ingram Douglas SPresident & CEO | PPurchase | +25.2K | $79.36 | +$2.00M | +6.9%390.3K after | 4 lots |
| Aug 15, 2023 (view filing) | Aug 14 | 1 day | Chambers Michael AndrewDirector | PPurchase | +9.98K | $109.47 | +$1.09M | +4.2%247.0K after | 2 lots |
| Aug 14, 2023 (view filing) | Aug 11 | 3 days | Chambers Michael AndrewDirector | PPurchase | +23.7K | $108.05 | +$2.56M | +11.1%237.0K after | |
| Aug 11, 2023 (view filing) | Aug 10 | 1 day | Chambers Michael AndrewDirector | PPurchase | +34.9K | $106.15 | +$3.70M | +19.5%213.3K after | 3 lots |
| Aug 8, 2023 (view filing) | Aug 4 | 4 days | Wigzell Hans Lennart RudolfDirector | SSale | −15.0K | $106.72 | −$1.60M | −41.7%21.0K after | |
| Nov 21, 2022 (view filing) | Nov 17 | 4 days | Mayo StephenDirector | SSale | −858 | $109.92 | −$94.3K | −11.8%6.39K after | |
| Sep 15, 2022 (view filing) | Sep 14 | 1 day | Chambers Michael AndrewDirector | PPurchase | +57.1K | $104.43 | +$5.96M | +111.8%108.2K after | 3 lots |
| Aug 22, 2022 (view filing) | Aug 19 | 3 days | Chambers Michael AndrewDirector | PPurchase | +46.2K | $108.28 | +$5.00M | +940.7%51.1K after | 2 lots |
| Nov 29, 2021 (view filing) | Nov 24 | 5 days | Rodino-Klapac LouiseHead of R&D, CSO | PPurchase | +3.78K | $79.33 | +$299.9K | +6.1%65.7K after | |
| Nov 17, 2021 (view filing) | Nov 17 | Same day | Ingram Douglas SPresident & CEO | PPurchase | +25.0K | $79.94 | +$2.00M | +7.4%365.1K after |